The Thoc1 Ribonucleoprotein and Prostate Cancer Progression

BACKGROUND: The majority of newly diagnosed prostate cancers will remain indolent, but distinguishing between aggressive and indolent disease is imprecise. This has led to the important clinical problem of overtreatment. THOC1 encodes a nuclear ribonucleoprotein whose expression is higher in some ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Chinnam, Meenalakshmi, Wang, Yanqing, Zhang, Xiaojing, Gold, David L., Khoury, Thaer, Nikitin, Alexander Yu, Foster, Barbara A., Li, Yanping, Bshara, Wiam, Morrison, Carl D., Payne Ondracek, Rochelle D., Mohler, James L., Goodrich, David W.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271031/
https://ncbi.nlm.nih.gov/pubmed/25296641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju306
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados